首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Ipilimumab/nivolumabColitis: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2018年
/ 1700卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-018-45722-y
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:150 / 150
相关论文
共 50 条
[21]
Ipilimumab/nivolumabColitis: 2 case reports
[J].
Reactions Weekly,
2019,
1735
(1)
: 160
-
160
[22]
Ipilimumab/nivolumabColitis: 2 case reports
[J].
Reactions Weekly,
2020,
1788
(1)
: 135
-
135
[23]
Ipilimumab/nivolumabColitis: 3 case reports
[J].
Reactions Weekly,
2022,
1928
(1)
: 213
-
213
[24]
Ipilimumab/nivolumabColitis, hyperthyroidism and type 1 diabetes mellitus: case report
[J].
Reactions Weekly,
2018,
1705
(1)
: 174
-
174
[25]
Ipilimumab/NivolumabColitis
[J].
Reactions Weekly,
2024,
2005
(1)
: 464
-
464
[26]
Ipilimumab/nivolumabColitis and diarrhoea: 11 case reports
[J].
Reactions Weekly,
2020,
1810
(1)
: 120
-
120
[27]
Infliximab/ipilimumab/nivolumabColitis and acute drug induced liver injury: case report
[J].
Reactions Weekly,
2019,
1754
(1)
: 194
-
194
[28]
Ipilimumab/nivolumabColitis, meningoencephalitis and thyroiditis: 2 case reports
[J].
Reactions Weekly,
2022,
1930
(1)
: 316
-
316
[29]
NivolumabColitis: case report
[J].
Reactions Weekly,
2021,
1885
(1)
: 413
-
413
[30]
NivolumabColitis: case report
[J].
Reactions Weekly,
2017,
1672
(1)
: 201
-
201
←
1
2
3
4
5
→